Reaktionsgleichung
Cl.[Cl:2][C:3]1[CH:11]=[CH:10][C:6]([C:7]([NH2:9])=[NH:8])=[CH:5][CH:4]=1.[Cl:12][C:13]1[CH:14]=[C:15]([S:20](Cl)(=[O:22])=[O:21])[CH:16]=[CH:17][C:18]=1[F:19]>>[Cl:12][C:13]1[CH:14]=[C:15]([S:20]([NH:8][C:7](=[NH:9])[C:6]2[CH:10]=[CH:11][C:3]([Cl:2])=[CH:4][CH:5]=2)(=[O:21])=[O:22])[CH:16]=[CH:17][C:18]=1[F:19]Komponenten
3
Versuchsvorschrift
4-chlorobenzamidine hydrochloride (0.025 g, 0.133 mmol) and 3-chloro-4 fluorophenyl sulfonylchloride (0.0304 g, 0.133 mmol); were used essentially as described in Example 114 to prepare the title compound. ES Positive Ion MS [M+H]+ ions observed: m/z 347 (35Cl, 35Cl), m/z 349 (37Cl, 37Cl) and m/z 351 (37Cl, 37Cl).
Quellen und Nachweise
- ORD-Eintrag
- ord-de2086c618724f19854538d46869cde7
- Quelldatensatz
- uspto-grants-2007_02
- Patentnummer
- US07183320B2
Verknüpfte Notizen
Wird geladen…